The Michael J. Fox Foundation supports research projects through six Requests for Applications (RFAs) that span our strategy to define, measure and treat Parkinson’s. Deadline for pre-proposals is October 22, 2020.
MJFF funding opportunities  https://www.michaeljfox.org/webinar/mjff-funding-opportunities-spring-2021?em_cid=mc-a1b1R000008uUi6&et_cid=1676670&et_rid=225334131&et_lid=Register+Now.&em_id=%%

Open RFAs  

• Accelerating Publication of Parkinson’s Disease Replication Data: In partnership with the Journal of Parkinson’s Disease, the program supports the publication of results from experiments that attempted to replicate previously published findings from other laboratories.

• Analysis of Patient-Reported Outcomes from Fox Insight: Funds analyses of the patient-reported outcomes (PROs) and genetic data collected through the Fox Insight study.

• Development and Validation of Improved Outcome Measures: Funds the development of biomarkers that can improve definitive diagnosis, objectively track the progression of disease, enrich for subject populations, or more precisely detect treatment response or target engagement.

• PIPETTE: 4R Tau and Alpha-Synuclein PET Tracer Development: Funds the development of novel PET tracers for tau and alpha-synuclein through a partnership with the Rainwater Charitable Foundation.

• Target Advancement Program: Funds research to validate targets and define pathways implicated in Parkinson’s pathological processes and/or symptomology.

• Therapeutic Pipeline Program: Funds novel or repositioned, pre-clinical and clinical therapeutic intervention development for Parkinson’s. Specific interest in (1) developing therapeutics for non-motor symptoms and (2) telehealth-based therapeutic interventions.

 
Informational Webinar
Attend our webinar on September 3, 2020, at 12 p.m. ET to learn more about our Foundation's funding strategy and opportunities, and the application and review processes. Register Now.

The Outcomes Measures, Target Advancement and Therapeutic Pipeline programs are Edmond J. Safra Core Programs for PD Research.